Form4insider filings, from the source

SEC Form 4/A · accession 0001140361-16-066592

Emergent BioSolutions Inc. · EBS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Period of report
May 18, 2016
Accepted (ET)
May 23, 2016 · 8:39 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2May 18, 2016D7,833$0.00D30,300D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

Although Mr. Niederhuber has resigned from the Emergent BioSolutions Inc. Board of Directors, he continues as a consultant to the Scientific Review Committee of the Board of Directors. Accordingly, his unvested restricted stock units were not forfeited upon his resignation.